The debate over banning or legalizing marijuana has recently been going on for more than a century now, but it continues to be a new issue on the table. There are people who strongly support its legalization, while there are many who emphatically oppose it. Yet , over the last decade, the debate has been bent for cannabis as the term “medical marijuana” has gained momentum by making use of legalization campaigns. Still, there are others who are protecting against it from going it all legal. CBD VS CBD
The conclusions of a recent analyze also go in prefer of optimum medical use of marijuana. It says that the certain chemical found in marijuana can actually help in treating patients with drug-resistant varieties of epilepsy. This new study has provided evidence that cannabis can be effective in treatment for one-third of epilepsy patients who have a treatment-resistant form of the disease.
The analyze titled “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial” – published in The Lancet Neurology – says that almost one-third of epilepsy patients are treatment-resistant and are associated with severe morbidity and increased death. Though marijuana-based treatments for epilepsy have spiked the interest of the individuals, technological data on the subject matter is very limited, feel the authors.
“We directed to establish whether addition of cannabidiol to existing anti-epileptic regimens would be safe, tolerated, and suitable in children and youngsters with treatment-resistant epilepsy, very well the researchers said.
The researchers, led by Orrin Devinsky, neurologist at New York University Langone Clinic, administered an remove of 99 percent cannabidiol (CBD) – a non-psychoactive chemical in marijuana – to 162 patients and monitored them for about 12 weeks. The substance was given as a supplement or add-on and various other preexisting medicines of the patients and was conducted on an open level, this means everyone was aware of what they received. The researchers observed this intervention managed to reduce to motor seizures at an identical rate by the existing drugs, but 2 percent of patients became completely seizure free.
Inspite of some results being shown by this method, the researchers feel that there exists need for further intensive studies on the subject matter. “Our findings claim that cannabidiol might reduce seizure frequency and might have an enough safety account in children and young adults with highly treatment-resistant epilepsy. Randomized manipulated studies are warranted to define the safety profile and true efficacy of this compound, ” the research said.
This may not be the first time when such an observation has been made. Some previous studies experienced also drawn similar findings. A 2007 study, named “Marijuana: A powerful Antiepileptic Treatment in Partial Epilepsy? A Case Report and Assessment of the Literature, very well published in the Evaluations in Neurological Diseases got also said that “marijuana or its active matters may have a place in the treatment of partial epilepsy. “